These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9772121)

  • 1. Soy protein, isoflavones and cardiovascular disease risk.
    Lichtenstein AH
    J Nutr; 1998 Oct; 128(10):1589-92. PubMed ID: 9772121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soy foods, isoflavones, and the health of postmenopausal women.
    Messina M
    Am J Clin Nutr; 2014 Jul; 100 Suppl 1():423S-30S. PubMed ID: 24898224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of soy isoflavones on atherosclerosis: potential mechanisms.
    Anthony MS; Clarkson TB; Williams JK
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1390S-1393S. PubMed ID: 9848505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects.
    Sanders TA; Dean TS; Grainger D; Miller GJ; Wiseman H
    Am J Clin Nutr; 2002 Aug; 76(2):373-7. PubMed ID: 12145009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
    Jenkins DJ; Kendall CW; Jackson CJ; Connelly PW; Parker T; Faulkner D; Vidgen E; Cunnane SC; Leiter LA; Josse RG
    Am J Clin Nutr; 2002 Aug; 76(2):365-72. PubMed ID: 12145008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats.
    Peluso MR; Winters TA; Shanahan MF; Banz WJ
    J Nutr; 2000 Sep; 130(9):2333-42. PubMed ID: 10958832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits.
    Yamakoshi J; Piskula MK; Izumi T; Tobe K; Saito M; Kataoka S; Obata A; Kikuchi M
    J Nutr; 2000 Aug; 130(8):1887-93. PubMed ID: 10917898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women.
    Gardner CD; Newell KA; Cherin R; Haskell WL
    Am J Clin Nutr; 2001 Apr; 73(4):728-35. PubMed ID: 11273847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phyto-oestrogens and cardiovascular disease risk.
    van der Schouw YT; de Kleijn MJ; Peeters PH; Grobbee DE
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):154-67. PubMed ID: 11006924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.
    Sacks FM; Lichtenstein A; Van Horn L; Harris W; Kris-Etherton P; Winston M;
    Circulation; 2006 Feb; 113(7):1034-44. PubMed ID: 16418439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflavones, substances with multi-biological and clinical properties.
    Ren MQ; Kuhn G; Wegner J; Chen J
    Eur J Nutr; 2001 Aug; 40(4):135-46. PubMed ID: 11905954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats.
    Constantinou AI; Lantvit D; Hawthorne M; Xu X; van Breemen RB; Pezzuto JM
    Nutr Cancer; 2001; 41(1-2):75-81. PubMed ID: 12094632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy.
    West SG; Hilpert KF; Juturu V; Bordi PL; Lampe JW; Mousa SA; Kris-Etherton PM
    J Womens Health (Larchmt); 2005 Apr; 14(3):253-62. PubMed ID: 15857272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy and cardiovascular disease: cholesterol lowering and beyond.
    Anthony MS
    J Nutr; 2000 Mar; 130(3):662S-3S. PubMed ID: 10702605
    [No Abstract]   [Full Text] [Related]  

  • 15. Beyond the Cholesterol-Lowering Effect of Soy Protein: A Review of the Effects of Dietary Soy and Its Constituents on Risk Factors for Cardiovascular Disease.
    Ramdath DD; Padhi EM; Sarfaraz S; Renwick S; Duncan AM
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28338639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women.
    Baum JA; Teng H; Erdman JW; Weigel RM; Klein BP; Persky VW; Freels S; Surya P; Bakhit RM; Ramos E; Shay NF; Potter SM
    Am J Clin Nutr; 1998 Sep; 68(3):545-51. PubMed ID: 9734729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates.
    Kavanagh K; Jones KL; Zhang L; Flynn DM; Shadoan MK; Wagner JD
    Nutr Res; 2008 Jun; 28(6):368-76. PubMed ID: 19083434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys.
    Anthony MS; Clarkson TB; Hughes CL; Morgan TM; Burke GL
    J Nutr; 1996 Jan; 126(1):43-50. PubMed ID: 8558324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of soy-isoflavones in cardiovascular disease. Identification of molecular targets.
    Wenzel U; Fuchs D; Daniel H
    Hamostaseologie; 2008 Feb; 28(1-2):85-8. PubMed ID: 18278168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.